7/26/19 SHR # 2380 : Peptides That Help Resolve Stroke, TBI & CTE

By Elizabeth F. Yurth, MD | Peptides

Mar 27

Over 700,000 people suffer a stroke ever year. Add to that 2.5 million who suffer Traumatic Brain Injuries. Both of these may result in Chronic Encephalopathy – a degeneration of the brain tissue. Physicians have little in their toolbox to halt or reverse the collateral damage done to the brain. Now there are peptides than may not only stop the degenerative progression, but reverse and resolve the damage and allow for the restoration of all faculties.

Listen to this Podcast

Contact Us!

Questions About Peptides?

Boulder Longevity Institute is home to the nation's 1st Medically Managed Peptide Program for Human Optimization. If you're interested in learning more, give us a call today. (303)443-0848

About the Author

Along with her almost 25 years in practice in non-surgical orthopedics, and her Stanford-affiliated Fellowship in Sports and Spine Medicine, Dr. Yurth has received her American Board of Anti-Aging/Regenerative Medicine (ABAARM) Board Certification from the American Academy of Anti-Aging Medicine (A4M), has completed her Fellowship in Anti-Aging and Regenerative Medicine (FAARM) and her Advanced Fellowship in Anti-Aging, Regenerative and Functional Medicine (FAARFM) also through A4M. She has also completed an independent fellowship in Epigenetic and Human Potential Medicine and is now part of the nation's very first cohort of Certified Peptide Specialiist through A4M. Dr. Yurth is an inaugural member of the International Peptide Society (IPS) and is an IPS/A4M faculty member and lecturer.